Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00824252 · ClinicalTrials.gov registry record
Spousal Support in Head and Neck Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 361
- Enrollment target
NCT00824252: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00824252 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 361 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00824252 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 361 participants
- Enrollment target
Study Summary
The goal of this research study is to look at social and relationship factors that may affect the quality of life of patients with head and neck cancer and their spouses.
Interventions
- BEHAVIORAL Questionnaires & Study Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2008-12-08 |
| Est. Completion | 2022-02-23 |
What the finished NCT00824252 record still lists
NCT00824252 is an observational study that tracks outcomes without assigning an intervention. The registered 361 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires & Study Visit is the first listed.
NCT00824252 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00824252 about?
NCT00824252 is a clinical study titled "Spousal Support in Head and Neck Cancer". The goal of this research study is to look at social and relationship factors that may affect the quality of life of patients with head and neck cancer and their spouses.
What is the current status of trial NCT00824252?
This trial is currently completed. The enrollment target is 361 participants. The study started on 2008-12-08. Estimated completion is 2022-02-23.
What interventions are being tested in trial NCT00824252?
The interventions under investigation include: Questionnaires & Study Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT00824252?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05533697 · 361 participants · Phase 1
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI